{
  "casebody": {
    "data": "<casebody firstpage=\"327\" lastpage=\"328\" xmlns=\"http://nrs.harvard.edu/urn-3:HLS.Libr.US_Case_Law.Schema.Case_Body:v1\">\n<parties data-order=\"0\" data-type=\"parties\" id=\"b359-12\">PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA, Plaintiff-Appellee, v. Peter E. WALSH, Acting Commissioner, Maine Department of Human Services and G. Steven Rowe, Attorney General for the State of Maine, Defendants-Appellees, v. Edwin D. Schindler, Non Party Movant-Appellant.</parties>\n<docketnumber data-order=\"1\" data-type=\"docketnumber\" id=\"b359-17\">No. 03-1499.</docketnumber>\n<court data-order=\"2\" data-type=\"court\" id=\"b359-18\">United States Court of Appeals, Federal Circuit.</court>\n<decisiondate data-order=\"3\" data-type=\"decisiondate\" id=\"b359-19\">DECIDED: Nov. 3, 2003.</decisiondate>\n<p data-order=\"4\" data-type=\"judges\" id=\"b359-20\">Before CLEVENGER, RADER, and SCHALL, Circuit Judges.</p>\n<opinion data-order=\"5\" data-type=\"opinion\" id=\"x999-1\" type=\"majority\">\n<author id=\"b359-22\">CLEVENGER, Circuit Judge.</author>\n<p id=\"b359-23\">\n<em>ORDER</em>\n</p>\n<p id=\"b359-24\">Edwin D. Schindler responds to the court\u2019s order directing him to show cause why his appeal should not be transferred to the United States Court of Appeals for the First Circuit.</p>\n<p id=\"b359-25\">In order for this court to have jurisdiction over Schindler\u2019s appeal of the order of the United States District Court for the District of Maine denying his motion for leave to intervene, the district court\u2019s jurisdiction must have arisen under the patent laws. 28 U.S.C. \u00a7\u00a7 1295(a)(1) and 1338. In <em>Holmes Group, Inc. v. Vornado Air Circulation Systems, Inc., </em>535 U.S. 826, <page-number citation-index=\"1\" label=\"328\">*328</page-number>830, 122 S.Ct. 1889, 153 L.Ed.2d 13 (2002), the Supreme Court held:</p>\n<blockquote id=\"b360-4\">The well-pleaded-complaint rule has long governed whether a case \u201carises under\u201d federal law for purposes of \u00a7 1331. As \u201cappropriately adapted to \u00a7 1338(a),\u201d the well-pleaded-complaint rule provides that whether a case \u201carises under\u201d patent law \u201cmust be determined from what necessarily appears in the plaintiffs statement of his own claim in the bill or declaration....\u201d The plaintiffs well-pleaded complaint must \u201cestablis[h] either that federal patent law creates the cause of action or that the plaintiffs right to relief necessarily depends on resolution of a substantial question of federal patent law....\u201d</blockquote>\n<p id=\"b360-5\">(Citations omitted.)</p>\n<p id=\"b360-6\">In this case, plaintiff Pharmaceutical Research and Manufacturers of America\u2019s complaint is devoid of any patent claims and, thus, the district court\u2019s jurisdiction was not based on \u00a7 1338. Notwithstanding Schindler\u2019s assertion that his \u201cIntervenor\u2019s Complaint,\u201d if allowed, would contain patent claims, jurisdiction is not properly before this court. <em>Cf. Fuller v. Volk, </em>351 F.2d 323, 327 (3d Cir.1965) (holding that the \u201coriginal plaintiffs,\u201d versus the intervenors, \u201cmust bring their case within the ambit of federal question jurisdictional provisions, 28 U.S.C. \u00a7 1331, in order that this court and the court below may have jurisdiction\u201d).</p>\n<p id=\"b360-7\">Accordingly,</p>\n<p id=\"b360-8\">IT IS ORDERED THAT:</p>\n<p id=\"b360-9\">This case is transferred to the United States Court of Appeals for the First Circuit pursuant to 28 U.S.C. \u00a7 1631.</p>\n</opinion>\n</casebody>\n",
    "status": "ok"
  }
}